About two-thirds of the global population under age 50 has HSV-1. The World Health Organization estimates that 3.8 billion people in that age group, or 64%, carry the virus. In the United States, the rate is lower and has been declining: roughly 48% of people aged 14 to 49 tested positive for HSV-1 antibodies in the most recent national survey data.
Global Prevalence by Region
HSV-1 rates vary dramatically depending on where you live. Africa has the highest prevalence, with about 87% of people under 50 carrying the virus regardless of sex. The Western Pacific region (which includes China, Japan, and Australia) follows at around 73 to 74%. Europe sits at 61% for men and 69% for women, while the Americas have the lowest regional rates at 39% for men and 49% for women.
These differences largely reflect how early in life people are exposed. In regions where HSV-1 prevalence is very high, most people contract the virus during childhood through casual contact like a kiss from a family member or sharing utensils. In countries with lower rates, more people reach adolescence and adulthood without prior exposure, which changes how and where they eventually pick up the virus.
Prevalence in the United States
The U.S. stands out for having rates well below the global average, and those rates have been falling. National health survey data from the CDC shows that HSV-1 prevalence among people aged 14 to 49 dropped from 59.4% in 1999-2000 to 48.1% in 2015-2016, a decline of more than 11 percentage points. Women are slightly more likely to carry the virus (50.9%) than men (45.2%).
Prevalence climbs steadily with age. Among U.S. teenagers aged 14 to 19, about 27% have HSV-1. That rises to 41% in people in their twenties, 54% in their thirties, and nearly 60% by the time people reach their forties. This pattern simply reflects more years of potential exposure.
Why Declining Rates Create a New Problem
Falling HSV-1 rates might sound like good news, and in some ways they are. But there’s a counterintuitive consequence. When fewer people catch HSV-1 as children (typically as oral herpes, or cold sores), more teenagers and young adults encounter the virus for the first time through sexual contact. This means a growing share of genital herpes cases are now caused by HSV-1 rather than HSV-2.
A 2023 meta-analysis calculated that 37.4% of genital herpes cases are now attributed to HSV-1, with the remaining 62.1% caused by HSV-2. That’s a significant shift from decades past, when genital herpes was almost exclusively an HSV-2 issue. Childhood exposure to HSV-1 provides some cross-protective immunity, so populations where oral HSV-1 infection happens early tend to see fewer genital HSV-1 cases later.
Most People Never Know They Have It
The majority of people with HSV-1 have no symptoms or such mild ones that they never realize they’re infected. Standard blood tests look for antibodies to the virus, and while they’re generally reliable, they aren’t perfect. Current automated tests have high specificity (above 97% for the best-performing assays, meaning few false positives) but sensitivity can fall below 85%, meaning some infections go undetected.
Even without symptoms, the virus can still be transmitted. Research from the University of Washington tracked people with genital HSV-1 and found they shed virus on about 12% of days at two months after infection, dropping to 7% of days by 11 months. In most instances, participants had no symptoms during shedding episodes. For those who were still shedding at higher rates, a follow-up two years after infection showed the rate had fallen further to just 1.3% of days. This declining pattern over time is one reason genital HSV-1 tends to cause fewer recurrences and less transmission than genital HSV-2.
HSV-1 and Pregnancy
The timing of a mother’s infection matters far more than the infection itself when it comes to risk during childbirth. A mother experiencing her first HSV outbreak at the time of delivery faces transmission rates to the newborn as high as 60%. For a non-primary first episode (meaning the mother has antibodies to one type of HSV but is newly infected with the other), the risk is up to 45%.
By contrast, mothers with a history of recurrent HSV infections have a transmission risk below 2%. Their immune systems have already built up antibodies that partially protect the baby, and they shed less virus for shorter periods during reactivation. Recent data also shows a trend toward more neonatal herpes cases being caused by HSV-1 rather than HSV-2, consistent with the broader shift in genital herpes epidemiology.
What the Numbers Mean in Practice
If you carry HSV-1, you’re in the majority worldwide and close to it in the United States. The virus is so widespread that public health agencies don’t recommend routine screening for people without symptoms. Most carriers were infected in childhood and experience rare or no outbreaks throughout their lives. For those who do get cold sores, outbreaks typically become less frequent over time as the immune system builds a stronger response to the virus.
The people most affected by shifting HSV-1 patterns are young adults in countries like the U.S., where declining childhood exposure means first infections increasingly happen later in life and through sexual contact. This doesn’t change the nature of the virus itself, but it does change where on the body it shows up and how people experience it emotionally and socially.